Aerpio Therapeutics Report issue

For profit Phase 1 Phase 2
Founded: Cincinnati OH United States (2011)
Status: Acquired by Aadi, LLC (2021)

Organization Overview

First Clinical Trial
2012
NCT01702441
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Aerpio Therapeutics